Evaluation of Knowledge Regarding Gestational Diabetes and Evaluation of (Group) Education for Gestational Diabetes
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Gestational Diabetes
- Sponsor
- Universitaire Ziekenhuizen KU Leuven
- Enrollment
- 200
- Locations
- 1
- Primary Endpoint
- Evaluation of the knowledge regarding GDM with a self-designed questionnaire
- Status
- Completed
- Last Updated
- 5 years ago
Overview
Brief Summary
Prospective observational cohort study of women with gestational diabetes (GDM) based on the 'International Association of Pregnancy Study Groups' (IADPSG) criteria. The overall aim is to evaluate the knowledge regarding GDM of women with GDM and to evaluate the satisfaction of women with GDM about the education they receive (given in group or individually). Normal routine care is followed and evaluated.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Women ≥ 18 years diagnosed with GDM in the university hospital Leuven.
Exclusion Criteria
- •Women who received bariatric surgery.
- •Women with pregestational diabetes or diagnosed with diabetes during early pregnancy.
Outcomes
Primary Outcomes
Evaluation of the knowledge regarding GDM with a self-designed questionnaire
Time Frame: over a 2-4 week period
Scale (0 to 3) with questionnaire on depression (CES-D )
Time Frame: over a 2-4 week period
Evaluation of satisfaction with education and Diabetes Treatment Satisfaction Questionnaire
Time Frame: over a 2-4 week period
Scale (1-4) with questionnaire on anxiety (six-item short form STAI)
Time Frame: over a 2-4 week period
Secondary Outcomes
- The prevalence of GDM based on the IADPSG criteria(at 24-28 weeks of pregnancy)
- Composite endpoint of glycaemic control, weight, gestational weight gain and pregnancy outcomes(over a period of 16 weeks)
- The frequency of insulin therapy for GDM(over a period of 16 weeks)
- The time between the glucose challenge test and oral glucose tolerance test(at 24-28 weeks of pregnancy)
- The frequency of an HbA1c ≥6.5%(at 24-28 weeks of pregnancy)